Table 2.
Term/synonyms | Concept definition | Prioritization |
---|---|---|
Events of delivery | ||
Live Birth* S: Live born |
Delivery of an infant, regardless of maturity or birth weight, as determined by the presence of a heartbeat or spontaneous respirations or spontaneous movement | Enabling term or outcome |
Stillbirth* S: Stillborn Fetal Demise/Death Deadborn |
Delivery of a dead fetus after 22 weeks of gestation (WHO) | Priority outcome |
Categories: | ||
- Early Stillbirth Delivery ≥22 weeks and/or >500g | ||
- Late Stillbirth Delivery ≥28 weeks and/or >1000g | ||
Other commonly reported subgroups: | ||
- Antepartum or during pregnancy or “macerated” | ||
- Intrapartum, defined as no signs of life at delivery and more than 500 g or >22 weeks of gestation, with intact skin and no signs of disintegration in utero. The death is assumed to have occurred in the 12 h before delivery and to be more likely due to an intrapartum event. Excludes babies with severe congenital anomalies | ||
Perinatal death* | Death of fetus at or after 22 weeks of gestation and/or neonate up to 1 week (7 days) after birth | Priority outcome |
Neonatal death* | Death of a live newborn at any time from birth to 28 days of life, regardless of gestational age. | Priority outcome |
Subgroups: | ||
Very early neonatal death: <24 h | ||
Early neonatal death: birth to <7 days | ||
Late neonatal death: 7 to <28 days | ||
Infant death* | Death of a live born occurring from birth until 12 months of age | Priority outcome |
Subgroup: post-neonatal death: occurs between 28 days and 1 year of life | ||
Term birth* | Birth at ≥37 weeks to <42 weeks of gestation | Enabling term or outcome |
Preterm birth* | Birth before 37 weeks of gestation are completed | Priority outcome |
Subgroups: (WHO) | ||
Moderate to late Preterm: 32 to <37 weeks | ||
Very Preterm: 28 to <32 weeks | ||
Extreme Preterm: <28 weeks | ||
Early term birth* | Birth at 37 to <39 weeks of gestation | Outcome |
Post-term birth* S: Post-mature birth |
Birth on or after 42 weeks of gestation | Outcome |
Physical examination and anthropometric measurements | ||
Low Apgar Scores* | Score of less than 7 on a 10 point Apgar scale after 5 min | Outcome |
Low Birth Weight* | Birth weight below the normal birth weight range of 2500 to 3999 g | Priority outcome |
Subgroups: | ||
Low birth weight (LBW): <2500 g | ||
Very low birth weight (VLBW): <1500 g | ||
Extremely low birth weight (ELBW):<1000 g | ||
High birth weight* S: Macrosomia |
Birth weight ≥4000 g | Outcome |
Small for Gestational Age (SGA)* S: IUGR = intrauterine growth restriction |
Birth weight <10% for infants of same gestational age and gender in same population | Priority outcome |
Large for Gestational Age (LGA)* | Birth weight >90% for infants of same gestational age in same population | Outcome |
Birth length* | Crown-foot length in cm assessed in relation to gestational age | Enabling term |
Microcephaly* | Head circumference >2 Standard deviations below mean for gestational age, gender and ethnic origin | Outcome |
Macrocephaly* | Head circumference >2 standard deviations above mean for gestational age, gender and ethnic origin | Outcome |
Congenital anomalies* S: Birth defects Malformations |
Abnormalities of body structure or function that are present at birth and are of prenatal origin. (WHO) | Priority outcome |
MAJOR ANOMALIES | ||
Those that require surgical/medical treatment, have serious adverse effects on health or development (functional), or have significant cosmetic impact. | ||
MINOR ANOMALIES | ||
Those that do not in themselves have serious medical, functional or cosmetic consequences for the child. Includes those found in association with major anomalies | ||
Neonatal conditions classified by organ system | ||
Systemic conditions | ||
Asphyxia* | Insufficient oxygen supply to organs at birth resulting from inadequate ventilation or perfusion | Priority outcome |
Fever* | Elevated body temperature at or above 38 °C measured at least once (BC)a | Outcome |
Hypothermia | Decreased body temperature below 36 °C | Taskforce key term |
Infection* | Infection regardless if acquired in utero, intrapartum or in neonatal period | Priority outcome |
Congenital infection: Acquired in utero at any time of gestation and prior to delivery | ||
Key Event: Infection caused by organism for which mother received vaccination during pregnancy (vaccine associated or vaccine failure) | ||
Sepsis | Infection associated with cardiovascular collapse and systemic, multiorgan involvement. | Taskforce key term |
Neonatal sepsis: Sepsis diagnosed in the first 28 days of life. | ||
Accepted Categories: | ||
(WHO) | ||
Early onset: <7 days of age | ||
Late onset: 7–90 days of age | ||
(NCS) Early onset: <72 h of life | ||
Late onset: ≥72 h of life | ||
Sudden infant death syndrome* S: SIDS, cot death |
Sudden death of any child under 12 months of age which remains unexplained after excluding other causes of death (BC)b | Priority outcome |
Failure to thrive or growth deficiency* | Inability to maintain expected growth rate over time, evaluated by plotting individual weight gain and growth on standard growth charts for the population | Suggested outcome and taskforce key term |
Respiratory tract | ||
Respiratory distress* | Increase in respiratory rate above normal range for age and labored breathing (nasal flaring, grunting, retractions, pallor and cyanosis or hypoxemia). May be transient or persistent | Suggested outcome |
Transient tachypnea of newborn S: TTN |
Respiratory distress beginning shortly after birth and usually resolving over 24–48 h or within 3 days of delivery. | Taskforce key term |
Usually associated with retained lung fluid after delivery AND Cesarean section delivery with or without labor in term or preterm infants usually >35 weeks of gestation | ||
Meconium Aspiration syndrome S: MAS Aspiration pneumonia |
Respiratory distress syndrome associated with presence of meconium stained amniotic fluid in the lungs during or before delivery. | Taskforce key term |
Usually associated with fetal distress prior to and at the time of delivery in term or post-term infants AND visual inspection of trachea and larger airways by endotracheal intubation and suctioning to determine the presence of meconium stained amniotic fluid | ||
Respiratory distress syndrome S: RDS Hyaline membrane disease Surfactant deficiency syndrome |
A respiratory syndrome in premature infants caused by developmental insufficiency of surfactant production and structural immaturity in the lungs. Begins shortly after birth and is manifest by respiratory distress | Taskforce key term |
Persistent pulmonary hypertension of the newborn S: PPHN Persistent fetal circulation |
Persistence of fetal circulatory pattern of right to left shunting through the patent ductus arteriosus and foramen ovale after birth due to excessively high pulmonary vascular resistance. Begins shortly after birth, usually within the first 12 h of life, and is manifest by respiratory distress AND hypoxemia that is unresponsive to 100% oxygen and out of proportion with findings in chest X-ray. Usually occurs in term infants | Taskforce key term |
Apnea* | Cessation of breathing for 15 (or 20) s or more, or a shorter respiratory pause associated with bradycardia, cyanosis or hypoxemia, pallor, and/or hypotonia. Should be distinguished from periodic breathing | Suggested outcome |
Pneumonia | An inflammatory condition of the lung affecting primarily the alveoli. It is usually caused by infection with viruses or bacteria. | Taskforce key term |
Key event: Infection caused by organism for which mother received vaccination during pregnancy | ||
Chronic lung disease S: Bronchopulmonary dysplasia (BPD) |
A chronic lung disorder characterized by inflammation and scarring in the lungs that is most common among infants who were born prematurely and result in need for supplemental oxygen | Taskforce key term |
Neurologic/neuromuscular | ||
Neonatal Hypoxia* S: Neonatal Asphyxia |
Decreased arterial concentration of oxygen and insufficient blood flow to cells or organs to maintain their normal function, particularly the central nervous system. | Taskforce key Term and Suggested outcome |
Related terms: | ||
Asphyxia = insufficient oxygen supply to organs due to poor ventilation or poor perfusion | ||
Anoxia = complete lack of oxygen | ||
Hypoxia = decreased arterial concentration of oxygen | ||
Ischemia = insufficient blood flow to maintain normal organ function | ||
Neonatal Encephalopathy* S: Birth Asphyxia Perinatal Asphyxia |
Injury to the central nervous system that occurs when there is insufficient delivery of oxygen or blood to all or part of the brain (NCS) | Priority outcome and Taskforce key term |
OR | ||
A disturbance of neurological function manifested by difficulty initiation and maintaining respiration, depression of tone and reflexes, abnormal level of consciousness and often seizures. | ||
1. Due to intrapartum hypoxic insult | ||
2. Due to another cause | ||
May be mild, moderate or severe. | ||
Assessed by clinical and laboratory findings including: 5 min Apgar score of 0–3; Respiratory distress and Acidosis (pH < 7.0); Altered tone, depressed level of consciousness, seizures; Multiorgan involvement; Abnormal CNS imaging or EEG. May result in neonatal death or permanent damage to the brain and other organs. May be associated with perinatal events, rarely to prenatal events | ||
Hypoxic Ischemic Encephalopathy* S: HIE |
A syndrome of abnormal neurological behavior in the neonate, which is frequently associated with multi-system dysfunction and follows severe injury before or during delivery, associated with hypoxic and/or ischemic event. | Priority outcome and Taskforce key term |
May be mild, moderate or severe. | ||
Comment: The term Neonatal Encephalopathy, specifying if it is associated with intrapartum event, is preferred | ||
Lethargy | Reduced responsiveness to environmental stimuli | Taskforce key term |
Irritability* | Abnormal responsiveness to stimuli or physiologic arousal, may be in response to pain, fright, a drug, emotional situation or a medical condition (CTCAE) | Suggested outcome |
Seizure* S: Convulsion |
Witnessed sudden loss of consciousness AND generalized, tonic, clonic, tonic–clonic, or atonic motor manifestations (BC)c | Suggested outcome |
Hypotonia/hypertonia | Decreased or increased muscular tone for gestational and post-natal age | Taskforce key term |
Hyporreflexia/hyperreflexia | Decreased or increased reflexes for gestational and post-natal age | Taskforce key term |
Meningitis | Inflammatory process of the meninges (BC)d | Taskforce key term |
Meningoencephalitis | Inflammatory process of the meninges and brain parenchyma (BC)e | Taskforce key term |
Intracranial intraventricular hemorrhage S: IVH |
Bleeding in the ventricles or brain parenchyma | Taskforce key term |
Associated with prematurity or other factors such as trauma, RDS, hypoxia–ischaemia, hypo- or hypertension, other maternal and fetal factors. | ||
Periventricular leucomalacia S: PVL |
Decreased perfusion, periventricular hemorrhage and/or necrosis in the periventricular white matter and/or white matter, Associated with prematurity and IVH, hypoxia-ischemia, other maternal and fetal factors | Taskforce key term |
Sleeping issues* | Disturbance in sleep pattern | Suggested outcome |
Neurodevelopmental disability* | Alteration in progression or regression of normal development of motor, speech or cognitive skills as expected for gestational and post-natal age | Suggested outcome |
Assessed by medical history, physical examination, and standard screening and assessment tools appropriate for age. Serial assessment required due to variability in individual acquisition of skills. Assessment at or beyond 1 year of age more likely to represent true disability | ||
Cardiovascular | ||
Tachycardia/Bradycardia* | Heart rate above or below normal range for age and gestational age | Suggested enabling term |
Hypertension/Hypotension | Blood pressure above or below normal range for age, gestational age, gender and length and height | Taskforce key term |
Heart failure | Cardiac dysfunction resulting in symptoms | Taskforce key term |
Hematologic | ||
Bleeding* | Loss of blood from any site or etiology | Suggested outcome |
Assessed by Evidence of bleeding AND symptoms that may include tachycardia, hypotension, diaphoresis, lethargy, pallor, cyanosis, shock AND Anemia (low hemoglobin or hematocrit) | ||
Anemia* | Hematocrit or hemoglobin concentration below the lower limit of normal range for gestational age and post-natal age | Suggested outcome |
Polycythemia | Hematocrit or hemoglobin concentration above the upper limit of normal range for gestational age and post-natal age | Taskforce key term |
Thrombocytopenia* | Platelet count below the lower limit of normal range for gestational age and post-natal age (BC)f | Suggested outcome |
Leukopenia | Decreased white blood cell count below lower limit of normal range for gestational and post-natal age | Taskforce key term |
Leukocytosis* | Increased white blood cell count above upper limit of normal range for gestational and post-natal age | Suggested outcome |
Coagulopathy S: DIC Disseminated intravascular coagulation |
Bleeding and/or clotting disorder associated with abnormal activation of coagulation pathways | Taskforce key term |
Gastrointestinal | ||
Difficulty feeding* | Poor suck and/or inability to maintain adequate oral intake for age | Suggested outcome |
Vomiting | Reflexive act of ejecting stomach contents through the mouth | Taskforce key term |
Diarrhea | Increase in frequency and/or change in consistency (liquid) of stools for age (BC)g | Taskforce key term |
Necrotizing enterocolitis | Disease of the gastrointestinal tract characterized by mucosal or transmural necrosis of the intestine. | Taskforce key term |
Jaundice/Hyperbilirubinemia* | Elevation of Total and/or Direct–Indirect bilirubin for gestational and post-natal age Subgroups: | Suggested outcome |
Physiologic hyperbilirubinemia | ||
Neonatal hyperbilirubinemia | ||
Direct/Conjugated hyperbilirubinemia | ||
Indirect/Unconjugated hyperbilirubinemia | ||
Breastfeeding Jaundice | ||
Hepatic dysfunction | Elevation of liver enzymes and/or coagulopathy | Taskforce key term |
Metabolic | ||
Hypoglycemia | Low serum glucose concentration (mg/dL) below lower limit of normal for gestational and post-natal age | Taskforce key term |
Hypocalcemia/Hypercalcemia | Concentration of serum (mg/dL) or ionized Calcium below or above the lower and upper limits of normal for gestational and post-natal age | Taskforce key term |
Hypomagnesemia/Hypermagnesemia | Concentration of serum (meq/L) magnesium below or above the lower and upper limits of normal for gestational and post-natal age | Taskforce key term |
Renal | ||
Renal insufficiency | Decreased urinary output and/or elevation of serum creatinine above upper limit of normal for gestational and post-natal age | Taskforce key term |
Renal failure | Persistent oliguria or anuria with decreased creatinine clearance for gestational and post-natal age | Taskforce key term |
Electrolyte anomalies (Na, K) | Concentration of serum (meq/L) sodium or potassium below or above the lower and upper limits of normal for gestational and post-natal age | Taskforce key term |
Other | ||
Birth trauma or injury | Neonatal injury associated with delivery | Taskforce key term |
Assessed by physical exam AND birth history | ||
Allergic conditions* | Infant allergic disorders | Suggested outcome |
Autoimmune disorders* | Maternal and infant autoimmune disorders | Suggested outcome |
Infant Immunity* | Effect of maternal antibodies on infant responses to active vaccination and/or natural infection Effect of maternal antibodies on infant reactogenicity after active vaccination |
Suggested outcome |
Gender specific events* | Infant events related to gender | Suggested outcome |
Sources of Accepted Definitions: WHO: World Health Organization; BC: Brighton Collaboration; NCS: National Children’s Study; CTCAE: Common Terminology Criteria for Adverse Events (National Institutes of Health); NICHD: National Institute of Child Health and Human Development.
BC-WHO Consultation consensus term.
See Brighton definition: Michael Marcy, S., et al., Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine, 2004. 22(5–6): p. 551–6.
See Brighton Definition: Jorch, G., et al., Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, 2007. 25(31): p. 5707–16.
See Brighton definition: Bonhoeffer, J., et al., Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine, 2004. 22(5–6): p. 557–62.
See Brighton definition: Tapiainen, T., et al., Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine, 2007. 25(31): p. 5793–802.
See Brighton definition: Sejvar, J.J., et al., Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, 2007. 25(31): p. 5771–92.
See Brighton definition: Wise, R.P., et al., Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, 2007. 25(31): p. 5717–24.
See Brighton definition: idudu, J., et al., Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, 2010. 29(5): p. 1053–71.